Patent Assignment
Reel/Frame 019966/0026
Assignment of Assignor's Interest
Recorded: 2007-09-11
Pages: 27
Assignor
APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Executed: 2007-08-27
Assignee
LABORATOIRES SERONO SA
CENTRE INDUSTRIEL, COINSINS, VAUD, 1267, SWITZERLAND
Covered Properties
(309)
Site-Directed Mutagenesis Modified Glycoprotein Hormones
Patent:
5,260,421 →
Application:
07/136,236 →
Dram Cell and Array
Application:
07/244,575 →
Novel Method of Ovulation Induction in Humans
Patent:
5,087,615 →
Application:
07/324,949 →
Rose Plant - Meigrelou Variety
Patent:
7,313 →
Application:
07/354,285 →
Saf Polypeptide, Gene Coding Therefor, Saf Promoter and Expression Methods for Expressing Foreign Dna Sequences in Streptomyces
Patent:
5,118,617 →
Application:
07/410,706 →
Combined Treatment with Gnrh Antagonist and Gnrh to Control Gonadotropin Levels in Mammals
Patent:
5,180,711 →
Application:
07/538,375 →
Treatment of Obesity with an Alpha-2-Adrenergic Agonist and a Growth Hormone Releasing Peptide
Patent:
5,120,713 →
Application:
07/580,686 →
Management of Infertility
Patent:
5,175,111 →
Application:
07/592,441 →
Ovulation Kit Comprising Fsh Isoforms with Varying Half-Lives
Patent:
5,262,518 →
Application:
07/751,016 →
Protein Complex Enhancing Sperm Motility
Patent:
5,304,464 →
Application:
07/777,277 →
Method for the Modification of the Expression Characteristics of an Endogenous Gene of a Given Cell Line
Patent:
5,272,071 →
Application:
07/893,447 →
Optical Waveguide Assay Unit and Method of Improving Assay Sensitivity Using Same
Patent:
5,369,717 →
Application:
07/930,690 →
Somatostatin - Active Polypeptide Composition
Patent:
5,491,131 →
Application:
07/945,836 →
Determining of Substrate of Coenzyme Requiring Enzyme
Patent:
5,356,780 →
Application:
08/030,151 →
Liquid Level Detecting Mechanism and Ink Jet Recording Apparatus Having the Mechanism
Application:
08/074,465 →
Method and Apparatus for Growing Biomass Particles
Patent:
5,654,197 →
Application:
08/102,098 →
Method for Impproving Sperm Motility
Patent:
5,453,354 →
Application:
08/108,000 →
Fishing Lure Which Releases the Involuntary Biting Reflex of Largemouth Bass and Other Fishes Within the Family Centrarchidae
Application:
08/117,583 →
Site-Directed Mutagenesis Modified Dna Encoding Glycoprotein Hormones and Methods of Use
Patent:
5,352,779 →
Application:
08/126,134 →
Treatment of Polycystic Ovarian Disease
Patent:
6,489,288 →
Application:
08/197,501 →
Site-Directed Mutagenesis Modified Glycoprotein Hormones and Methods of Use
Patent:
5,986,068 →
Application:
08/281,123 →
Method of Assay Having Calibration Within the Assay
Patent:
5,726,064 →
Application:
08/309,796 →
Pharmaceutical Compositions Containing Il-6
Patent:
5,635,176 →
Application:
08/335,874 →
Method for Improving Measurement Precision in Evanescent Wave Optical Biosensor Assays
Patent:
5,631,170 →
Application:
08/351,338 →
Pharmaceutical Composition and Uses Therefor
Patent:
5,925,344 →
Application:
08/367,124 →
Human Fc Gamma Receptor Iii
Patent:
5,976,831 →
Application:
08/417,488 →
CD16-Ii Variants
Patent:
6,444,789 →
Application:
08/433,123 →
Kit for Use in Treatment of Polycystic Ovarian Disease
Patent:
6,492,177 →
Application:
08/436,023 →
Granulocyte Chemotactic Protein
Patent:
5,840,524 →
Application:
08/436,420 →
Site-Directed Mutagenesis Modified Glycoprotein Hormones and Methods of Use
Patent:
5,635,475 →
Application:
08/442,645 →
Site-Directed Mutagenesis Modified Glycoprotein Hormones and Methods of Use
Patent:
5,705,479 →
Application:
08/442,963 →
New Protein from Urine Named Component B
Patent:
5,908,827 →
Application:
08/448,561 →
Method of Expressing and Secreting Soluble Extracellular Domains of Human Gonadotropin Hormone Receptors
Patent:
6,033,903 →
Application:
08/460,576 →
A Method of Using Aspirin to Implant an Embryo
Patent:
5,760,024 →
Application:
08/464,785 →
Methods for Assaying Human Fsh Using Human Fsh Receptor
Patent:
6,372,711 →
Application:
08/474,986 →
Interleukin-1 Antagonist
Patent:
5,739,282 →
Application:
08/476,860 →
Human Fc-Gamma Receptor Iii
Patent:
5,767,077 →
Application:
08/481,939 →
Dna Encoding Human Follicle Stimulating Hormone Receptor,Vectors and Cells Containing Suchdna,and Methods of Use Thereof
Patent:
6,121,016 →
Application:
08/482,855 →
Human Follicle Stimulating Hormone Receptor
Patent:
5,744,448 →
Application:
08/487,886 →
Anti-Foam Device for a Bioreactor
Patent:
5,612,219 →
Application:
08/557,134 →
Sensor Device for Sandwich Assay
Patent:
5,856,203 →
Application:
08/663,243 →
CD16-Ii Variants
Patent:
5,998,166 →
Application:
08/667,939 →
Spectrophotometric Techniques
Patent:
5,766,957 →
Application:
08/716,213 →
Soluble Polypeptide Fractions of the Lag-3 Protein; Production Method, Therapeutic Composition, Anti-Idiotype Antibodies
Patent:
5,955,300 →
Application:
08/737,271 →
Ifn-Beta Liquid Formulations
Patent:
6,852,314 →
Application:
08/737,633 →
Hgh Containing Pharmaceutical Compositions
Patent:
5,898,030 →
Application:
08/750,684 →
Sensor for Optical Assay
Patent:
5,994,091 →
Application:
08/779,201 →
Hybrid Proteins
Patent:
6,193,972 →
Application:
08/804,166 →
Soluble Human Prolactin Receptors
Patent:
6,083,714 →
Application:
08/806,597 →
Assay Method with Improved Release of Soluble Reagents
Patent:
6,309,893 →
Application:
08/809,394 →
Pharmaceutical Composition for Stimulation of the Immune System
Application:
08/817,595 →
Publication:
US 2003/0045453
Gp 130 Lacking the Transmembrane Domain
Patent:
5,965,724 →
Application:
08/825,558 →
Human Scf, a Splice Variant Thereof, Its Pharmaceutical Use
Patent:
6,177,556 →
Application:
08/836,252 →
Methods for Altering Fertility
Patent:
7,001,597 →
Application:
08/867,587 →
Dna Encoding Interleukin-1 Antagonist
Patent:
5,837,495 →
Application:
08/910,733 →
Antibodies to Interleukin-1 Antagonists.
Patent:
5,981,713 →
Application:
08/910,884 →
Hybrid Proteins
Patent:
6,194,177 →
Application:
08/910,991 →
Hcg Liquid Formulations
Patent:
6,706,681 →
Application:
08/913,748 →
Medicaments for Initiating Ovulation
Patent:
6,407,057 →
Application:
08/930,560 →
Il-6 Activity Inhibitor
Patent:
6,004,813 →
Application:
08/945,726 →
Soluble Human Prolactin Receptors
Patent:
6,083,753 →
Application:
08/970,428 →
Tnf Receptor and Steroid Hormone in a Combined Therapy
Patent:
6,225,300 →
Application:
08/983,223 →
Use of Aspirin for the Manufacture of a Medicament for Implanting an Embryo into the Uterine Endometrium
Patent:
6,100,249 →
Application:
08/985,590 →
Capillary-Fill Biosensor Device Comprising a Calibration Zone
Patent:
6,027,944 →
Application:
08/998,185 →
Il-6 as Serum Uric Acid Decreasing Compound
Patent:
6,007,804 →
Application:
09/027,618 →
Soluble Polypeptide Fractions of the Lag-3 Protein; Production Method, Therapeutic Composition, Anti-Idiotype Antibodies
Patent:
6,143,273 →
Application:
09/058,555 →
Use of Human Chorionic Gonadotropin in the Treatment of Kaposi's Sarcoma
Patent:
6,251,402 →
Application:
09/101,640 →
Disulfide Crosslinked Glycoprotein Hormone Analogs, and Their Preparation and Use
Patent:
8,530,190 →
Application:
09/104,400 →
Il-6 Mutein
Patent:
6,280,975 →
Application:
09/155,941 →
Component B as Cicatrizant
Patent:
5,998,364 →
Application:
09/171,659 →
Method of Assay
Patent:
6,991,938 →
Application:
09/180,335 →
Reconstituting Device for Injectable Medication
Patent:
6,645,171 →
Application:
09/194,873 →
IFNAR2/Ifn Complex
Patent:
6,372,207 →
Application:
09/215,212 →
Human Fcy Receptor Iii
Patent:
6,294,347 →
Application:
09/232,218 →
Hcg and Derivatives as Matrix Metalloproteases Inhibitors
Ice Inhibiting Peptides
Patent:
6,380,162 →
Application:
09/297,369 →
GP130 Lacking the Transmembrane Domain
Patent:
6,380,160 →
Application:
09/312,611 →
Fsh Mimetics for the Treatment of Infertility
Patent:
6,235,755 →
Application:
09/369,222 →
Intracellular Glucocorticoid-Induced Leucine Zippers Modulators of Apoptic Cell Death Pathways
Patent:
6,833,348 →
Application:
09/403,861 →
Labels for Containers
Patent:
6,550,171 →
Application:
09/433,623 →
Pharmaceutical Compositions of Peptides Having Low Solubility in Physiological Medium
Patent:
6,331,520 →
Application:
09/451,013 →
Pharmaceutical Compositions Thereof, and Methods of Using Same
Patent:
6,337,316 →
Application:
09/460,384 →
Human Growth Hormone to Stimulate Hematopoiesis and Immune Reconstitution After Hematopoietic Stem Cell Transplantation in Humans
Patent:
6,348,444 →
Application:
09/465,461 →
Treatment of Hiv-Associated Dysmorphia/Dysmetabolic Syndrome (Hadds) with or Without Lipodystrophy
Patent:
6,696,063 →
Application:
09/475,989 →
Use of Benzo[C]Quinolizine Derivatives as Plant Growth Regulators
Patent:
6,514,912 →
Application:
09/480,238 →
Allelic variant of human stat3
Patent:
6,369,198 →
Application:
09/526,542 →
21-Hydroxy-6, 19-oxidoprogesterone (21OH-6OP) and its use as medicament for treating excess of glucocorticoids
Patent:
6,303,591 →
Application:
09/533,225 →
Amino-Terminally Truncated Rantes as Chemokine Antagonists
Amino-Terminally Truncated Mcp-2 as Chemokine Antagonists
Site-Specific Preparation of Polyethylene Glycol-Grf Conjugates
Patent:
6,528,485 →
Application:
09/587,460 →
Benzo(C)Quinolizine Derivatives and Their Use as 5 Alpha-Reductases Inhibitors
Patent:
6,962,925 →
Application:
09/593,173 →
Inhibition of Tnf Activity
Patent:
6,608,044 →
Application:
09/623,225 →
Method for Producing a Heterologous Secreted Protein from Chinese Hamster Ovary Cells Grown on Microcarriers
Patent:
6,458,565 →
Application:
09/654,353 →
Tnf Receptor and Steroid Hormone in a Combined Therapy
Patent:
7,012,060 →
Application:
09/687,122 →
Polyol-Ifn-Beta Conjugates Modified at Cys-17 and Composition Containing Same
Patent:
6,638,500 →
Application:
09/698,133 →
Peg-Lhrh Analog Conjugates
Patent:
6,433,135 →
Application:
09/698,134 →
Il-6 Antagonist Peptides
Patent:
6,599,875 →
Application:
09/715,923 →
Fsh Mimetics for the Treatment of Infertility
Patent:
6,423,723 →
Application:
09/723,495 →
Process for the Synthesis of (1-H)-Benzo[C]Quinolizin-3-Ones Derivatives
Patent:
6,723,850 →
Application:
09/743,373 →
Compound B as Angiogenic Agent in Combination with Human Growth Factors
Hybrid Heterodimeric Protein Comprising a Tnf Binding Protein and a Glycoprotein Hormone Subunit, and Method of Using Same
Chemokine Receptor Antagonist and Cyclosporin in Combined Therapy
Patent:
6,902,728 →
Application:
09/787,335 →
Expression and secretion of icil- 1 receptor antagonist type II
Application:
09/807,610 →
Methods for Monitoring Fsh or Fsh Mimetic Influenced Cellular Processes
Application:
09/854,434 →
Publication:
US 2003/0162692
Pharmaceutically Active Compounds and Methods of Use
Hcg Therapy for the Treatment of Breast Cancer
Patent:
7,183,251 →
Application:
09/868,196 →
Benzo [C] Quinolizine Derivatives, Their Preparation and Use as 5ALPHA-Reductases Inhibitors
Tumor Necrosis Factor Antagonists and Their Use in Endometriosis
Patent:
6,663,865 →
Application:
09/889,828 →
Benzo[C]Quinolizine Derivatives, Their Preparation and Use as 5ALPHA-Reductases Inhibitors
Soluble Polypeptide Fractions of the LAG03 Protein, Production
Patent:
38,313 →
Application:
09/931,103 →
Combined Treatment of Multiple Sclerosis
Patent:
6,869,600 →
Application:
09/958,351 →
Gonadotrophins in the Treatment Anovulatory Women
Patent:
7,695,721 →
Application:
09/959,799 →
IL6RIL6 Chimera for the Treatment of Neurodegenerative Diseases
Patent:
7,201,896 →
Application:
09/980,823 →
Reconstituting Device for Injectable Medication
Methods of Inducing Ovulation
Process for the improvement of spermatozoa fertilization activity
Application:
10/048,013 →
Pharmaceutically Active Sulfonamide Derivatives
Patent:
8,012,995 →
Application:
10/070,954 →
Pharmaceutically Active Sulfonyl Hydrazide Derivatives
Patent:
7,432,286 →
Application:
10/088,074 →
Pharmaceutically Active Sulfonyl Amino Acid Derivatives
Patent:
7,638,538 →
Application:
10/088,090 →
9- (Piperazinylalkyl) Carbazoles as Bax-Modulators
Patent:
8,053,436 →
Application:
10/110,199 →
Allelic Variant of Human STAT3
Medicaments for Initiating Ovulation
Automated Method for Identifying Related Biomolecular Sequences
Patent:
6,996,474 →
Application:
10/148,124 →
Fsh Mimetics for the Treatment of Infertility
Benzazole Derivatives and Their Use as Jnk Modulators
Method for the Identification of Gene Transcripts with Improved Efficiency in the Treatment of Errors
Use of Fsh for Treating Infertility
Amine Derivatives for the Treatment of Apoptosis
Peg-Lhrh Analog Conjugates
Use of il-18 inhibitors
Application:
10/204,387 →
Publication:
US 2003/0157094
Purified Lh
Process of Purification of Hcg and Recombinant Hcg Purified by That Method
Monoclonal Antibodies to the Human Ldl Receptor, Their Production and Use
Pharmaceutically Active Pyrrolidine Derivatives
Pharmaceutically Active Pyrrolidine Derivatives as Bax Inhibitors
Use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosis
Application:
10/275,341 →
Publication:
US 2004/0076628
Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
Application:
10/297,755 →
Publication:
US 2004/0028649
Site-Specific Preparation of Polyethlene Glycol-Grf Conjugates
Early Diagnosis of Conformational Diseases
Optical Fiber and Optical Fiber Wiring Board Using the Optical Fiber
Mehtod of Producing Functional Protein Domains
Il-6 Antagonist Peptides
Sulphur Analogues of 21-Hydroxy-6,19-Oxidoprogesterone (21OH-6OP) for Treating Excess of Glucocorticoids
Method for the Preparation of 21-Hydroxy-6,19-Oxidoprogesterone (21OH-6OP)
Pharmaceutically Active Benzsulfonamide Derivatives as Inhibitors of Protein Junkinases
Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
Application:
10/381,200 →
Publication:
US 2004/0077632
Pharmaceutically Active Sulfonamide Derivatives Bearing Both Lipophilic and Ionisable Moieties as Inhibitors of Protein Junkinases
Chemokine Mutants in the Treatment of Multiple Sclerosis
Pharmaceutically Active Sulfanilide Derivatives
Method of operating a computer system to perform a discrete substructural analysis
Application:
10/399,329 →
Publication:
US 2004/0083060
Use of Sarp-1 for the Treatment and/or Prevention of Scleroderma
Use of IL-18 inhibitors for the treatment and/or prevention of heart disease
Application:
10/470,303 →
Publication:
US 2004/0234523
Pyrrolidine Ester Derivatives with Oxytocin Modulating Activity
Method and kit for quantitation of polypeptides
Application:
10/473,043 →
Publication:
US 2004/0203077
Use of Osteopontin for the Treatment and/or Prevention of Neurologic Diseases
Method and Kit for Identifying and/or Quantifying Radiolabeled Aminoglycoside Binding Molecules
Pyrrolidine Oxadiazole- and Thiadiazole Oxime Derivatives Being Oxytocin Receptor Antagonists
Alkylidene Pyrazolidinedione Derivatives
Application:
10/481,240 →
Publication:
US 2004/0220188
Arylsulfonamide Derivatives as C-Jun-N-Terminal Kinases (Jnk's) Inhibitors
Use of il-18 inhibitors in hypersensitivity disorders
Application:
10/486,612 →
Publication:
US 2004/0247598
Use of Lh in Controlled Ovarian Hyperstimulation
Use of Hcg in Controlled Ovarian Hyperstimulation
Method for Aiding Implantation or Decreasing Miscarriage Rate
Methods of Increasing Endogenous Testosterone Levels
Application:
10/489,863 →
Publication:
US 2004/0198799
Azole Derivatives and Pharmaceutical Compositions Containing Them
Use of GP130 Activators in Diabetic Neuropathy
Pyrazolidinone Compounds as Ligands of the Prostaglandin EP2 and/or EP4 Receptors
Oxindole Hydrazide Modulators of Protein Tyrosine Phosphatases (Ptps)
Mutant Glycoproteins
Gonadotrophins for folliculogenesis
Application:
10/493,638 →
Publication:
US 2005/0085412
Method of treating estrogen responsive breast cancer
Application:
10/494,644 →
Publication:
US 2005/0002900
Method of treating endometreosis
Application:
10/494,699 →
Publication:
US 2005/0079156
Methods of Increasing Protein Expression Levels
Benzazole Derivatives for the Treatment of Scleroderma
Prion inhibiting peptides and derivatives thereof
Application:
10/497,160 →
Publication:
US 2005/0181998
Triazoles as Oxytocin Antagonists
Methods of Inducing Ovulation Using a Non-Polypeptide Camp Level Modulator
Novel raf/ras binding compounds
Application:
10/499,097 →
Publication:
US 2005/0164906
Chemokine Mutants Acting as Chemokine Antagonists
Pyrrolidine Derivatives as Prostaglandin Modulators
Substituted Methylene Amide Derivatives as Modulators of Protein Tyrosine Phosphatases(Ptps)
Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
Application:
10/508,014 →
Publication:
US 2005/0215605
Use of IL-18BP for treatment of peripheral vascular diseases
Chemokines Mutants Having Improved Oral Bioavailability
OX40R Binding Agents
Antagonists of Mcp Proteins
Use of Osteoprotegerin for the Treatment and/or Prevention of Fibrotic Disease
Piperazine Benzothiazoles as Agents for the Treatment of Cerebral Ischemic Disorders or Cns Disorders
Treatment of Hepatitis C in the Asian Population with Subcutaneous Interferon-Beta
Azole Methylidene Cyanide Derivatives and Their Use as Protein Kinase Modulators
Gamma Lactams as Prostaglandin Agonists and Use Thereof
Antagonists of CXCR3-Binding Cxc Chemokines
Pyrrolidine Derivatives as Oxytocin Antagonists
Beta-sheet breaking peptides
Application:
10/519,680 →
Use of compounds for increasing spermatozoa motility
Application:
10/519,685 →
Publication:
US 2005/0222225
Azolidinone-Vinyl Fused-Benzene Derivatives
Protein tyrosine phosphatase inhibitors
Application:
10/526,164 →
Publication:
US 2006/0241020
Piperazine Derivatives and Methods of Use
Novel chemokine-like polypeptides
Application:
10/530,104 →
Publication:
US 2006/0080744
Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer
Application:
10/530,106 →
Publication:
US 2006/0275299
Aza-Peptides
Application:
10/537,246 →
Publication:
US 2006/0281686
Novel ifngamma-like polypeptides
Application:
10/537,555 →
Publication:
US 2007/0016967
Methods of Reducing Serum Alanine Transferase Levels in a Subject with Hepatitis
Novel notch-like polypeptides
Application:
10/540,844 →
Publication:
US 2006/0141468
Novel preadipocyte factor-1-like polypeptides
Application:
10/540,845 →
Publication:
US 2006/0155117
Novel fibulin-like polypeptides
Application:
10/540,846 →
Publication:
US 2006/0228709
Novel fibrillin-like polypeptides
Application:
10/540,847 →
Publication:
US 2006/0248603
Piperazine-2-carboxamide derivatives
Combined use of ribavirin and interferon beta in demyelinating diseases
Application:
10/546,843 →
Publication:
US 2006/0276419
Pyrrolidine Derivatives as Oxytocin Antagonists
G-Lactam Derivatives as Prostaglandin Agonists
Method for the identification of syntenic regions
Application:
10/547,866 →
Publication:
US 2007/0154887
Expression Vectors Comprising the Mcmv IE2 Promoter
Amylin aggregation inhibitors and use thereof
Application:
10/549,502 →
Publication:
US 2007/0155955
Use of clusterin for the treatment and/or prevention of peripheral neurological diseases
Application:
10/550,775 →
Publication:
US 2007/0134260
Beta-Amyloid Inhibitors and Use Thereof
Application:
10/554,372 →
Publication:
US 2007/0293422
Pyridinyl Acetonitriles
Active Variants of the Il-18 Binding Protein and Medical Uses Thereof
Application:
10/556,417 →
Publication:
US 2008/0076708
Novel il-8-like polypeptides
Application:
10/557,234 →
Publication:
US 2007/0067858
Use of Prion Conversion Modulating Agents
Hydrazide Derivatives as Prostaglandin Receptors Modulators
Alkynyl Aryl Carboxamides
Aryl Dicarboxamides
Use of soluble cd164 in inflammatory and/or autoimmune disorders
Application:
10/565,741 →
Publication:
US 2006/0257402
2-Imino-4-(Thio) Oxo-5-Polycyclovinylazolines for Use as PI3 Kinase Inhibitors
Novel Therapeutic Fusion Proteins
Application:
10/566,929 →
Publication:
US 2007/0264236
Method for the Purification of a Non-Immunoglobulin Protein Comprising an Immunoglobulin-Like (Ig-Like) Domain
Novel ubp8rp polypeptides and their use in the treatment of psoriasis
Application:
10/570,121 →
Publication:
US 2007/0087983
Treatment of Fibrotic Disease
Benzothiazole derivatives for the treatment of diabetes
Application:
10/571,291 →
Publication:
US 2007/0088017
Benzoxazole acetonitriles
Application:
10/571,323 →
Publication:
US 2007/0185104
Sulfonamide Derivatives for the Treatment of Diabetes
Benzimidazole Acetonitriles
Application:
10/571,470 →
Publication:
US 2007/0203134
Leader sequences for use in production of proteins
Application:
10/573,369 →
Publication:
US 2007/0141666
Therapeutic Uses of Chemokine Variants
Novel CXCL8 antagonists
Application:
10/573,726 →
Publication:
US 2009/0022657
Minimal Dna Sequence Acting as a Chromatin Insulator and Its Use in Protein Expression
Methods for Identifying Modulators of Active Kit Tyrosine Kinase Receptor
Application:
10/579,286 →
Publication:
US 2007/0225202
Process for the Production of Tumor Necrosis Factor-Binding Proteins
Application:
10/582,952 →
Publication:
US 2007/0099266
Cc-Chemokine Binding Tick Proteins
Use of Il-6 in Liver Injury
Methods and compositions for the treatment of lipodystrophy
Application:
10/586,107 →
Publication:
US 2007/0161551
Use of methylene amide derivatives in cardiovascular disorders
Application:
10/590,808 →
Publication:
US 2007/0185118
Method for preparing pyrrolidine oximes
Application:
10/590,813 →
Publication:
US 2007/0197794
Method for fast substructure searching in non-enumerated chemical libraries
Application:
10/591,091 →
Publication:
US 2007/0260583
Anti-Lipid Rafts Antibodies
Application:
10/593,432 →
Publication:
US 2008/0057057
Intracellular Modulators of Apoptopic Cell Death Pathways
Improved Method for Treating Disorders and Diseases Treatable with Human Fibroblast Interferon
Tumor necrosis factor antagonists and their use in endometriosis
Application:
10/666,335 →
Publication:
US 2004/0057954
Improvement of Homogeneity and Secretion of a Recombinant Follicle Stimulating Hormone (Fsh) in Mammalian Systems
Treatment of Hiv-Associated Dysmorphia/Dysmetabolic Syndrome (Hadds) with or Without Lipodystrophy
Inhibitors of Phosphodiesterases in Infertility
Use of Slurp-1 Compositions for Treating Schizophrenia
Homogeneity and Secretion of Recombinant Proteins in Mammalian Systems
Luteinizing Hormone and Follicle Stimulating Hormone for Use in Inducing Folliculogenesis
Ifn-Beta Liquid Formulations
Pharmaceutically Active Compounds and Methods of Use
Fsh Beta Mutants That Are Glycosilated at Residues N55 and T57
Use of Osteoprotegerin for the Treatment and/or Prevention of Fibrotic Disease
Use of Osteopontin for the Treatment and/or Prevention of Neurologic Diseases
Use of Il-6-Type Cytokines for Maturation of Oocytes
Compound B as an Angiogenic Agent in Combination with Human Growth Factors
Site-Specific Preparation of Polyethylence Glycol-Grf Conjugates
Intracellular modulators of apoptopic cell death pathways
Application:
11/012,128 →
Publication:
US 2005/0095681
Use of Amino-Terminally Truncated Rantes to Inhibit Hiv Viral Replication
Pharmaceutical compositions containing extracted MHC molecules, for stimulation of the immune system
Application:
11/107,782 →
Publication:
US 2005/0238653
Amino-Terminally Truncated Mcp-2 as Chemokine Antagonists
Sulphur Analogues of 21-Hydroxy-6,19-Oxidoprogesterone (21OH-6OP) for Treating Excess of Glucocorticoids
Method for Inhibiting Hiv Viral Replication
Application:
11/131,221 →
Publication:
US 2005/0220790
Peg-Lhrh Analog Conjugates
Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP)
Application:
11/141,029 →
Publication:
US 2005/0277769
Methods of Inducing Ovulation
Expression and secretion of icIL-1 receptor antagonist type II
Application:
11/192,055 →
Publication:
US 2006/0293230
Methods for altering fertility
Application:
11/229,140 →
Publication:
US 2007/0253955
Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
Application:
11/237,876 →
Publication:
US 2006/0029581
Inhibitors of Phosphodiesterases in Infertility
Application:
11/276,459 →
Publication:
US 2006/0229288
Purified LH
Application:
11/287,341 →
Publication:
US 2006/0079460
TNF receptor and steroid hormone in a combined therapy
Application:
11/352,275 →
Publication:
US 2006/0142197
GRF-containing lyophilized pharmaceutical compositions
Application:
11/364,079 →
Publication:
US 2006/0160739
Pyrrolidine oxadiazole-and thiadiazole oxime derivatives being oxytocin receptor antagonists
Application:
11/449,802 →
Publication:
US 2006/0229343
Methods of Inducing Ovulation
Use of Slurp-1 for Treating Diseases Related to Acetylcholine Receptor Dysfunction
Use of GPCR54 Ligands for the Treatment of Infertility
Application:
11/547,293 →
Publication:
US 2007/0270339
1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives as Ptp 1-B Inhibitors
Composition Comprising a Jnk Inhibitor and Cyclosporin
Application:
11/547,967 →
Publication:
US 2008/0039377
Treatment of Hiv-Associated Dysmorphia/Dysmetabolic Syndrome (Hadds) with or Without Lipodystrophy
Application:
11/552,753 →
Publication:
US 2008/0004217
Rnai-Based Target Identification and Validation
Application:
11/568,066 →
N-Hydroxyamide Derivatives and Use Thereof
Pyridine Methylene Azolidinones and Use Thereof Phosphoinositide Inhibitors
Use of Pregnancy Specific Glycoprotein for Maturation of Oocytes
Application:
11/575,398 →
Publication:
US 2007/0282162
Use of Il-17-for Maturation of Oocytes
Application:
11/575,399 →
Publication:
US 2007/0231896
Use of Il-17F for the Treatment and/or Prevention of Neurologic Diseases
Application:
11/575,415 →
Publication:
US 2008/0286227
Use of Il-17 in the Treatment of Fertility-Related Disorders
Application:
11/596,416 →
Publication:
US 2008/0014172
Splice Variant of Unc5h2
Application:
11/597,986 →
Publication:
US 2008/0038255
Pharmaceutically Active Pyrrolidine Ester Derivatives
Application:
11/620,359 →
Publication:
US 2007/0129381
Capsules Containing Transiently Transfected Cells, Method for Preparing Same and Uses Thereof
Application:
11/659,174 →
Publication:
US 2007/0258901
P13 kinase gamma inhibitors for the treatment of anaemia
Application:
11/664,969 →
Publication:
US 2009/0042773
A Method for Producing Polyol-Ifn-Beta Conjugate
Use of Osteopontin for the Treatment and/or Prevention of Neurologic Diseases
Application:
11/679,735 →
Publication:
US 2007/0225214
Method And System For Identifying Gene-Trait Linkages
Application:
11/722,315 →
Publication:
US 2008/0091358
Method for the Preparation of 21-Hydroxy-6,19-Oxidoprogesterone (21OH-6OP)
Application:
11/734,628 →
Publication:
US 2007/0249826
Grf-Containing Lyophilized Pharmaceutical Compositions
Methods of Increasing Protein Expression Levels
Application:
11/778,593 →
Publication:
US 2008/0014635
Method of Inhibiting the Expression and/or the Activity of Jnk
Azole Derivatives and Pharmaceutical Compositions Containing Them
Pharmaceutically active pyrrolidine derivatives
Application:
11/783,341 →
Publication:
US 2008/0167318
Novel Arylamino N-Heteroaryl Compounds as Mek Inhibitors
Novel Heteroaryl-Substituted Arylaminopyridine Derivatives as Mek Inhibitors
Quick hard disk drive spin-up
Application:
60/691,744 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Dec 21, 1987
From: CHAPPEL, SCOTT C.; BERNSTINE, EDWARD G.
To: INTEGRATED GENETICS, INC., FRAMINGHAM
Reel/Frame 004806/0323 →
Assignment of Assignors Interest.
Mar 17, 1989
From: CHAPPEL, SCOTT C.
To: INTEGRATED GENETICS, INC., ONE MOUNTAIN RD., FRAMINGHAM, MA
Reel/Frame 005036/0454 →
Assignment of Assignors Interest.
May 19, 1989
From: S.N.C. MEILLAND & CIE
To: CONARD-PYLE COMPANY, THE, A CORP. OF PA
Reel/Frame 005079/0248 →
Assignment of Assignors Interest.
May 19, 1989
From: MEILLAND, ALAIN A.
To: S.N.C. MEILLAND & CIE
Reel/Frame 005126/0398 →
Assignment of Assignors Interest.
Sep 1, 1989
From: INTEGRATED GENETICS, INC.
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V., JOHN B. GORSIRAWEG
Reel/Frame 005138/0773 →
Assignment of Assignors Interest.
Mar 30, 1990
From: INTEGRATED GENETICS, INC.
To: GENZYME CORPORATION, 75 KNEELAND STREET, BOSTON, MA 02111 A DE CORP.
Reel/Frame 005264/0722 →
Assignment of Assignors Interest.
Mar 30, 1990
From: INTEGRATED GENETICS, INC.
To: GENZYME CORPORATION, 75 KNEELAND STREET, BOSTON, MA 02111 A DE CORP.
Reel/Frame 005264/0732 →
Assignment of Assignors Interest.
Apr 19, 1990
From: ORTEGA, ANTONIO D.; GIL, JOSE A.; GARCIA, TOMAS V.; MARTIN, JUAN F.
To: LABORATORIOS SERONO S.A.,
Reel/Frame 005274/0786 →
Assignment of Assignors Interest.
Jul 19, 1990
From: HODGEN, GARY D.
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V., 6 JOHN B. GORSIRAWEG CURACAO, NETHERLAND ANTILLES
Reel/Frame 005379/0046 →
Assignment of Assignors Interest.
Sep 10, 1990
From: MUGICA, JESUS D.
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 005448/0667 →
Assignment of Assignors Interest.
Dec 28, 1990
From: LUNENFELD, BRUNO; MENASHE, YEHESKEL
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 005565/0308 →
Assignment of Assignors Interest.
Mar 6, 1991
From: LABORATORIOS SERONO S.A.
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 005623/0426 →
Assignor Hereby Confirms That the Assignee Recorded at Reel 5264 Frame 0722 Was in Error and the Assignment Recorded at Reel 5138 Frame 0773 Recites the Correct Assignee.
Oct 16, 1991
From: GENZYME CORPORATION
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 005870/0987 →
Assignment of Assignors Interest.
Oct 5, 1992
From: ATTRIDGE, JOHN W.
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 006488/0284 →
Assignment of Assignor's Interest
Mar 17, 1993
From: ROBINSON, GRENVILLE ARTHUR; HURRELL, JOHN GORDON ROWAN
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. A COMPANY OF THE NETHERLANDS ANTILLES
Reel/Frame 006592/0901 →
Assignment of Assignor's Interest
Jun 10, 1993
From: CHAPPEL, SCOTT C.
To: APPLIED RESEARCH SYSTEMS
Reel/Frame 006581/0638 →
Assignment of Assignor's Interest
Jun 10, 1993
From: SAITO, ATSUSHI; OKUBO, AKIO; IKEDA, YASUHIKO
To: CANON KABUSHIKI KAISHA
Reel/Frame 006582/0801 →
Assignment of Assignor's Interest
Dec 3, 1993
From: JEM, KWAN-MIN; CEVEY, PIERRE FRANCOIS
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 006794/0312 →
Assignment of Assignor's Interest
Dec 20, 1993
From: VALENTINCIC, TINE B.
To: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
Reel/Frame 006860/0714 →
Assignment of Assignor's Interest
Dec 20, 1993
From: CAPRIO, JOHN T.
To: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
Reel/Frame 006860/0711 →
Assignment of Assignor's Interest
Dec 20, 1993
From: OGAWA, KAZUAKI
To: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
Reel/Frame 006860/0708 →
Assignment of Assignor's Interest
Jan 26, 1994
From: AKERLOF, EVA; POUSETTE, AKE
To: AKERLOF, EVA; POUSETTE, AKE; APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 006847/0093 →
Assignment of Assignor's Interest
Apr 18, 1994
From: LUNENFELD, BRUNO
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V., A CORP. OF NETHERLAND ANTILLES
Reel/Frame 006989/0890 →
Assignment of Assignor's Interest
Nov 10, 1994
From: SAMARITANI, FABRIZIO; RENDINA, FILIPPO
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 007323/0521 →
Assignment of Assignor's Interest
Dec 12, 1994
From: ATTRIDGE, JOHN WORTHINGTON
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 007325/0572 →